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Abstract 
Background: Genetic recombination plays an important role in evolution, facilitating the creation of new, favorable 
combinations of alleles and the removal of deleterious mutations by unlinking them from surrounding sequences. In 
most mammals, the placement of genetic crossovers is determined by the binding of PRDM9, a highly polymorphic 
protein with a long zinc finger array, to its cognate binding sites. It is one of over 800 genes encoding proteins with 
zinc finger domains in the human genome.
Results: We report a novel technique, Affinity-seq, that for the first time identifies both the genome-wide bind-
ing sites of DNA-binding proteins and quantitates their relative affinities. We have applied this in vitro technique to 
PRDM9, the zinc-finger protein that activates genetic recombination, obtaining new information on the regulation of 
hotspots, whose locations and activities determine the recombination landscape. We identified 31,770 binding sites 
in the mouse genome for the PRDM9Dom2 variant. Comparing these results with hotspot usage in vivo, we find that 
less than half of potential PRDM9 binding sites are utilized in vivo. We show that hotspot usage is increased in actively 
transcribed genes and decreased in genomic regions containing H3K9me2/3 histone marks or bound to the nuclear 
lamina.
Conclusions: These results show that a major factor determining whether a binding site will become an active hot-
spot and what its activity will be are constraints imposed by prior chromatin modifications on the ability of PRDM9 to 
bind to DNA in vivo. These constraints lead to the presence of long genomic regions depleted of recombination.
© 2015 Walker et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Genetic recombination plays an important role in 
evolution, facilitating the creation of new, favorable 
combinations of alleles and the removal of deleteri-
ous mutations by unlinking them from surrounding 
sequences. Recombination also assures the proper segre-
gation of homologous chromosomes at the first meiotic 
division, preventing aneuploidy. In mammals, as in yeast 
and higher plants, recombination is restricted to special-
ized sites along chromosomes, a kilobase or so in length, 
known as hotspots [1, 2], whose locations and relative 
activity determine patterns of inheritance from one gen-
eration to the next. There is now substantial evidence 
from population genetic studies of humans [3–5], genetic 
crosses in mice [6, 7] and cattle [8], and molecular studies 
of hotspots in mice [9–11], that recombination hotspot 
locations in mammals are determined by the zinc finger, 
DNA-binding protein PRDM9, which binds at recombi-
nation hotspots and trimethylates lysine 4 of histone H3 
[10, 11].
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PRDM9 is a highly polymorphic mammalian protein, 
with extensive variation reported both between and 
within species, including humans [3–7, 12], chimps [13, 
14], cattle [8], equids [15], and mice, for which over 100 
alleles have been reported [7, 16, 17]. The great major-
ity of this variation occurs in the tandemly arrayed zinc-
finger domain and involves changes in PRDM9’s DNA 
binding properties. Analyzing the binding properties of 
several individual PRDM9 binding sites in vitro, we pre-
viously found that binding requires the participation of 
every zinc finger in the PRDM9 tandem array, not only 
those that define the computationally derived binding 
motif, and that individual fingers vary in their contribu-
tion to determining binding specificity [18]. To extend 
these studies, we developed and now describe Affin-
ity-seq as an efficient, generalized in  vitro method for 
directly isolating and sequencing most genomic binding 
sites for a DNA binding protein and determining their 
relative binding affinities.
Despite the biological and evolutionary importance of 
mammalian hotspots, we lack an understanding of the 
factors and mechanisms that constrain their locations 
and activity. We have now used Affinity-seq to identify 
potential PRDM9 binding sites in vitro, and address the 
issue of identifying factors determining which of these 
sites are used in vivo and what their relative activity will 
be. We provide evidence that a set of prior chromatin 
modifications influences the likelihood that a potential 
PRDM9 binding site will be used in vivo. PRDM9 bind-
ing sites located in genomic regions with elevated levels 
of histone 3 lysine 9 di- or trimethylation (H3K9me2/3) 
or that are typically associated with the nuclear mem-
brane protein Lamin B1 have a decreased likelihood of 
becoming activated, as measured by their acquisition 
of H3K4me3 or double-stranded breaks. Conversely, 
binding sites in protein-coding genes are more likely to 
become activated, and this effect increases in genes with 
higher levels of transcriptional activity in germ cells. 
The magnitude of these influences on binding site usage 
in vivo is inversely related to the relative binding affinity 
of PRDM9 in vitro. We conclude that the choice of which 
binding sites are used in  vivo and what their relative 
activities will be reflects a balance between the intrinsic 
affinity of PRDM9 for its binding sites and the restric-
tions imposed by prior chromatin modifications. This 
association was further confirmed by ChIP-seq measure-
ments of PRDM9 binding in vivo.
Results
Affinity‑seq identifies genome‑wide PRDM9 binding sites
The general principle of the Affinity-seq method is out-
lined in Additional file  1: Figure S1. A DNA-binding 
domain is cloned and tagged with 6His-HALO and then 
expressed in E. coli; the 6His tag facilitates protein purifi-
cation (Additional file 2: Figure S2A), and the HALO tag 
contains a binding pocket that covalently binds ligands, 
facilitating attachment of a biotin moiety to the purified 
protein. DNA sheared to 180–200 bp is provided in con-
siderable excess to provide competition between DNA 
binding sites. Following binding, DNA–protein com-
plexes are then isolated on streptavidin beads and the 
DNA extracted for deep sequencing.
In the case of PRDM9, we used the terminal zinc 
finger domain of PRDM9Dom2 (PRDM9ΔZnF1Dom2, 
412–847 aa), the allele present in C57BL/6J (B6) mice, 
which exhibits allele-specific binding of known hotspot 
sequences in  vitro (Additional file  2: Figure S2B, hot-
spot specificity is as determined in [18]). This construct 
lacks the first zinc finger, which is widely separated from 
the remaining tandem array of 12 zinc fingers. Unlike 
the remaining fingers, which are highly polymorphic, 
this finger has been tightly conserved during mamma-
lian evolution, suggesting an important regulatory role 
in  vivo without being involved in determining DNA 
binding specificity. Expressed PRDM9Dom2 containing 
this separated finger (PRDM9ZnF1Dom2, 384–847 aa) 
has the same binding specificity; however, the efficiency 
of binding is severely reduced after purification (Addi-
tional file  2: Figure S2B). Its binding activity is partially 
restored when incubated with various other proteins in 
their native or denatured states (Additional file 2: Figure 
S2C) suggesting the importance of protein concentration 
in maintaining stability of purified PRDM9 and affecting 
its DNA binding activity (Additional file 2: Figure S2B).
Expressed PRDM9ΔZnF1Dom2 protein was partially 
purified by chromatography, first by SP-Sepharose and 
then on Ni2+ resin, to over 50 % purity estimated by sil-
ver staining (Additional file 2: Figure S2A). The purified 
protein is soluble and retains its DNA binding specificity 
as evidenced by its ability to bind synthetic oligonucleo-
tides in vitro [18] (Additional file 2: Figure S2B) for up to 
6 weeks at 4 °C without significant loss of activity. Further 
purification results in rapid loss of DNA binding activity 
and the protein cannot be stabilized by subsequent addi-
tion of extra protein (e.g. BSA). For this reason, a final 
purification step of PRDM9-DNA bound complexes is 
achieved in the Affinity-seq protocol itself (Additional 
file 2: Figure S2A).
Initially, we found 25,472 and 35,436 binding peaks at 
p < 0.01 threshold in two independent Affinity-seq exper-
iments with purified PRDM9Dom2 protein variant, using 
input genomic DNA as a control. Of these, 24,033 peaks 
were common (Additional file 3: Figure S3A), with a good 
correlation of activities between the two experiments 
(r2 = 0.933, Additional file 3: Figure S3B). To improve the 
signal-to-noise ratio, which influences the false positive 
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rate, we combined the data from the replicate samples 
and re-ran the peak-calling algorithm, again using input 
DNA as control. We obtained 31,770 PRDM9Dom2 bind-
ing sites (11.34 sequence peaks/Mb) in the B6 genome 
excluding the Y-chromosome. The peaks typically 
spanned a distance of ~320 bp (319.5–322.1 bp in 95 % 
bootstrap confidence interval), close to twice the length 
of the average DNA fragments minus the 34 bp length of 
a PRDM9Dom2 binding site determined previously [18] 
(Fig.  1a). A single PRDM9Dom2 binding motif matching 
the motif identified in in  vivo studies [9, 11] was pre-
sent at the central 150 bp of 96 % of the 31,770 sites. In 
contrast, no detectable motif was found in the adjacent 
150-bp regions at both sides of the central region. Addi-
tionally, genomic positions of the PRDM9 binding sites 
coincided with the central nucleosome-depleted region 
present in H3K4me3 hotspots used in vivo [11] (Fig. 1b). 
Collectively, these results confirm that Affinity-seq cor-
rectly identifies PRDM9 binding sites.
We did not find a significant correlation between the 
motif match and binding strength which suggested that 
the nucleotides present at the remaining positions can 
also influence binding strength. We further investigated 
this possibility by determining the nucleotide bias along 
the entire binding site and surrounding nucleotides. 
The distribution of nucleotides at any position outside 
the binding sites did not differ from genome average. 
However, there was a clear nucleotide bias at the posi-
tions corresponding to the entire binding site, typically 
with a preference for one or two nucleotides (Fig.  1c), 
with the exception of the three nucleotides correspond-
ing to the first finger and two nucleotides correspond-
ing to the last zinc finger in the array. In five positions 
in the site (8, 11, 13, 15, and 16), the major nucleotides 
Fig. 1 Affinity-seq determines genome-wide PRDM9 binding sites. a Shape of a representative Affinity-seq peak. The size and position of the 
inferred PRDM9 binding site are shown on top; the size and position of the corresponding H3K4me3 hotspot are shown on the bottom. b Compari-
son between the composite signals (obtained by aggregating across all hotspots in the genome) at H3K4me3 and Affinity-seq peaks centered on 
the inferred PRDM9 binding sites. c Distribution of nucleotide frequencies along PRDM9 binding sites including the flanking nucleotides. Distinct 
preferences can be seen over the entire binding sites; the strongest signals are detected at positions covered by the PRDM9Dom2 motif indicated 
on top (nucleotides 7–19). The sequence of the binding motif identified in the nucleosome-depleted regions of H3K4me3 peaks and the structure 
of the zinc finger domain of PRDM9Dom2 are shown above. Note that, except for the terminal fingers, nucleotide frequencies are distinctly different 
from genome average for all positions, including those outside the region of the computationally derived motif; that identical fingers (QDK, QVK 
and especially AVQ) vary in nucleotide frequencies depending on their location in the array, and that nucleotide frequencies at the same amino 
acid position (notably Q in fingers 3 and 4 v. 5 and 6) are strongly influenced by the identity of adjoining amino acids
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(8-G, 11-G, 13-T, 15-C, and 16-T) were present at >0.85 
frequency and could be considered virtually invariable. 
The minimum length of the binding site for the 12-finger 
PRDM9Dom2 ZnF array is 36 bp, three bp per finger, if all 
fingers equally participate in DNA binding. The length of 
the nucleotide sequence differing from random nucleo-
tide distribution (31 bp) is slightly shorter than the 36 bp 
needed to bind 12 zinc fingers and the 34 bp experimen-
tally determined for the Pbx1 binding site [18] which sug-
gests that the first and last fingers do not substantially 
contribute to sequence-specific binding.
PRDM9 ChIP‑seq
To provide comparison between in  vitro and in  vivo 
PRDM9 binding sites, we performed PRDM9 ChIP-seq 
in spermatocytes of 12–14  days post-partum (dpp) B6 
mice, a time when germ cells are enriched for the pre-
leptotene to zygotene stages of early meiosis and PRDM9 
is active [11, 19], using a custom-made antibody [19]. We 
detected 1709 peaks, 1578 of which overlapped Affin-
ity-seq binding sites. Although the PRDM9 ChIP-seq 
is much less sensitive than other methods for hotspot 
detection [19] and we recovered much lower number of 
PRDM9 ChIP-seq peaks, 92 % of them matched Affinity-
seq binding sites, with overlapping peak centers (Addi-
tional file 4: Figure S4). Individual review of each of the 
8 % additional peaks revealed a combination of false posi-
tives from the PRDM9 ChIP-seq and false negatives from 
the Affinity-seq assays.
In vivo hotspots
Having a catalog of in  vitro PRDM9 binding sites pro-
vided a new means of comparing in  vitro and in  vivo 
usage. In doing so we relied on the widely accepted model 
of recombination initiation in mammals, which supposes 
that hotspots are defined by the presence of a PRDM9 
binding site where PRDM9 attaches and trimethylates 
H3K4me3, and that this arrangement determines the 
eventual site of double strand breaks (DSB) formation. 
PRDM9-dependent H3K4me3 marks first appear in early 
leptonema and persist until early pachynema, when they 
disappear with the advance of DNA repair process [20]. 
DSB formation follows similar dynamics as determined 
by DMC1 foci [21]. These stages can be assayed in vivo 
by ChIP-seq for their respective molecular tags: PRDM9, 
H3K4me3, and the single-stranded DNA-binding pro-
tein DMC1 that marks DSBs. These assays all have differ-
ent sensitivities of detection; for this reason we consider 
that an in  vivo hotspot exists in principle when one of 
the three in vivo measures coincides with an Affinity-seq 
binding site. ChIP-seq for H3K4me3 was carried out in 
spermatocytes from 12 to 14  dpp B6 males. The previ-
ously reported DMC1 data [9] was obtained using adult 
males. Because the H3K4me3 and DSB data are appreci-
ably more sensitive and include all the PRDM9 ChIP-seq 
peaks, they together provided the means for a compre-
hensive analysis of in vivo hotspots. We found a total of 
15,884 Affinity-seq binding sites overlapping either an 
H3K4me3 peak or a DMC1 peak. About 600 peaks were 
coincident between H3K4me3 peaks from both B6-Prd-
m9Cst–KI and B6 [11] and had no DMC1 peak. These 
peaks were classified as ambiguous and removed leaving 
15,244 sites to be designated as in vivo and 15,886 sites to 
be designated as in vitro only PRDM9Dom2 binding sites.
Using this characterization of hotspots, only about a 
half (48.0 %) of the 31,770 Affinity-seq binding sites are 
used in vivo to any measurable extent. However, the sites 
used in  vivo did not have any significant feature differ-
ences from those detected in vitro only—the two groups 
of sites had same shape and width, and similar frequency 
of motif detection at the peak (97 % of in vivo and 93 % of 
in vitro only binding sites). No new motifs were detected 
in the remaining sites in either group. The nucleotide fre-
quencies along the binding sites were indistinguishable 
between the two groups. (Additional file 5: Figure S5).
Historical usage of Affinity‑seq binding sites
DNA resected at the site of DSBs is repaired using the 
partner chromatid as the template, leading to the predic-
tion that there should be strong evolutionary selection 
for mutations diminishing or inactivating the PRDM9 
binding site [22]. This prediction has been confirmed by 
comparison of human hotspot sequences in chimpan-
zees [12], and experimentally by transferring a Prdm9 
allele from the sub-species in which it arose into a naive 
genetic background [19]. We found strong evidence that 
Affinity-seq binding sites detected as hotspots in  vivo 
have accumulated mutations when their sequences were 
compared to the CAST/EiJ genome from the sub-species 
Mus musculus castaneus which lacks the PRDM9Dom2 
variant and where PRDM9Dom2 hotspots were not used 
historically (Fig. 2a, red line) [19]. There is slight but not 
significant increase in mutation frequency at Affinity-seq 
binding sites not detected as hotspots in vivo, suggesting 
that a large proportion of these sites either have never 
been used or have been used so infrequently that they 
have undergone little evolutionary selection for muta-
tions (Fig. 2a, black line).
Heterochromatic features block hotspot activation
Under the conditions of Affinity-seq, all DNA sequences 
are equally available to PRDM9 binding; in contrast, 
DNA in vivo is organized in chromatin, raising the ques-
tion whether chromatin imposed constraints on DNA 
access can influence binding site usage in  vivo. To do 
so, we compared binding site usage in  vivo in genomic 
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regions enriched for H3K9me2 and H3K9me3, both 
known for their role in heterochromatin formation, 
with regions lacking these modifications. Large organ-
ized chromatin K9-modifications domains (LOCKs) 
represent closed chromatin regions characterized by 
H3K9me2 that vary in size and position in different cell 
types [23]. Likewise, H3K9me3 domains exhibit broad 
enrichment patterns that are associated with consti-
tutive closed chromatin, but are also found in unique 
silenced loci [24]. The genome-wide extent of these two 
types of domains in germ cells from 12-dpp B6 males was 
determined by applying rseg, a Hidden Markov Model 
approach [25], to ChIP-seq data. Only 31  % of Affin-
ity-seq binding sites were activated within H3K9me3 
domains and 40  % within LOCKs/H3K9me2 (Fig.  2b), 
suggesting that prior chromatin modifications influence 
hotspot usage. In spermatocytes, as reported for other 
tissues [21, 22], these two types of marks cover broad 
domains along the chromosomes instead of forming 
distinct local peaks (Fig. 2c, Additional file 6: Figure S6, 
Fig. 2 Hotspot usage and chromatin marks. a Detection of historical hotspot usage using CAST/EiJ genome for SNP calling. SNPs from the CAST/EiJ 
genome were obtained from the Wellcome Trust Sanger Institute’s Mouse Genomes Project. SNP densities are significantly increased at the PRDM9 
binding sites of in vivo hotspots indicative of biased gene conversion at active hotspots, but only slightly so for sites that were not detectably active 
in vivo. Regions spanning 2 kb are centered and oriented based on the PRDM9 binding sites identified by Affinity-seq; SNP frequency for each 
nucleotide position is expressed as ratio of increase over the regional average. b Influence of genomic features on hotspot usage. The boundaries of 
H3K9me3 (+) or (−) and H3K9me2 (+) or (−) regions were determined using the corresponding ChIP-seq data and rseg. cLADs represent constitu-
tive Lamin B-associated domains, ciLADS represent regions never associated with Lamin B domains. Gene expression is determined by ChIP-seq 
in 12-dpp spermatocytes. The bars show the fraction of in vivo used Affinity-seq binding sites relative to the total number of Affinity-seq binding 
sites in each category. The sites in each group are counted as belonging to a category if they cross into or are encapsulated within its borders. The 
fractions for various genomic features representative of opened and closed chromatin environments reveal a consistent reduction of in vivo usage 
in heterochromatic regions. Highly expressed genes represent the top quartile of the genes expressed in testes of 12-dpp mice. The bars show the 
fraction of in vivo used Affinity-seq binding sites relative to the total number of Affinity-seq binding sites in each category. Standard error bars are 
calculated from the Poisson distribution. c Distribution of H3K9me2, H3K9me3, and hotspot-deficient regions along mouse Chromosome 1. Top 
to bottom in each chromosome, first panel, H3K9me3 enriched (up) or depleted (down) regions; second panel, H3K9me2 enriched and depleted 
regions; third panel, regions containing Affinity-seq but deficient in H3K4me3/DMC1 peaks (in vivo Affinity-seq sites) in dispersed regions identified 
by Rscan are represented as red rectangles, those associated with assembly gaps removed; fourth panel, recombination-deficient regions in Collabo-
rative Cross mice [30], red rectangles; fifth panel, alignability track from the UCSC browser showing assembly gaps and low mappability regions
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the two upper panels). The greater reduction in hotspot 
densities in H3K9me3 domains was associated with gene 
clusters whose expression is silenced in spermatocytes, 
including vomeronasal receptors and cytochrome P450s 
(Additional file  7: Figure S7). This reduction probably 
combines the inhibiting effects of closed chromatin and 
low gene expression levels (Fig. 2b, see below).
Considering the role of subnuclear localization of DNA 
in accessibility, we examined DNA regions that have been 
reported to be bound to the inner nuclear membrane 
protein Lamin B1 (cLADs) across a set of functionally 
unrelated mouse and human cell lines [26, 27]. We found 
that LADs reported in ES cell lines overlap strikingly 
with germ-cell LOCKs regions (Additional file 8: Figure 
S8) determined from our data. Similar overlap has been 
found in differentiated cell lines compared to ES cell lines 
[23]. Not surprisingly, hotspots are underrepresented in 
cLADs compared to DNA regions that are consistently 
not associated with cLADs (ciLADs) (Fig. 2b).
Hotspot usage and gene expression levels
H3K4me3 hotspots are more frequent in protein-coding 
genes than in intergenic regions (Fig.  2b), confirming 
prior observations regarding DSB hotspots [10]. To test 
whether gene expression can affect hotspot usage, we 
performed RNA-seq in B6 12-dpp germ cells, finding a 
strong dependence of levels of hotspot densities on gene 
expression (Fig. 2b).
Affinity‑seq binding sites and hotspot distribution 
along the chromosomes
To obtain an independent measure of the distribution of 
hotspots along the chromosomes in vivo, we searched for 
genomic regions that are enriched or deficient in their 
content of either Affinity-seq binding sites or in  vivo 
hotspots using Rscan statistics [28]. We found many hot-
spot-deficient regions lacking both H3K4me3 and DMC1 
peaks, mostly overlapping with H3K9me2/3 domains 
(Fig. 2c, Additional file 6: Figure S6, third panel in each 
chromosome), but unlike our previous report of a torrid 
zone with multiple hotspots [29], we failed to find regions 
enriched for hotspots.
About 74  % of hotspot-deficient regions, spanning 
a total of 426.6  Mb, were not deficient in Affinity-seq 
binding sites compared to the genome-wide average, 
indicating that they are truly hotspot-deficient and not 
simply regions in which it is difficult to correctly assign 
sequencing reads. The hotspot-deficient regions are also 
deficient in genetic crossing over. Notable in this regard 
is the 13-Mb region on the X chromosome (113–126 Mb) 
(http://www.ncbi.nlm.nih.gov/geo/, GSE52628 [11]). 
Affinity-seq identified 122 binding sites, or 9.38 sites/Mb, 
in this region, only marginally lower than the genome-
wide average of 11.34 peaks/Mb, showing that PRDM9 
has no difficulty binding DNA in this region. Indeed, only 
1.3 Mb of the entire 13-Mb region is reported as having 
mapping difficulties. Nevertheless, only 22 H3K4me3 or 
DMC1 hotspots were observed in this region, or 18  % 
of the detectable Affinity-seq binding sites compared 
to 48  % genome-wide. Moreover, this region is mark-
edly deficient in genetic crossing over. Compared to the 
genome-wide average recombination rate of 0.67 cM/Mb 
in female mice, the genetic recombination rate across this 
region proved to be only 0.029 cM/Mb among 1092 off-
spring of female B6 X CAST/EiJ F1 hybrids carrying two 
different Prdm9 alleles (Prdm9Dom2/Cst), and 0.023  cM/
Mb among 912 offspring of NOD/LtJ X C3H/HeJ F1 
hybrids carrying yet another Prdm9 allele (Prdm9Dom3/
Dom3) (Table  1), approximately 4  % of the genome-wide 
average. Similarly, 51 long regions having no crossovers 
(0.58–12.2  Mb) were found in all mouse chromosomes 
(except Chr 10 and Chr 11) in Collaborative Cross mice 
[30], where four different Prdm9 alleles are segregating 
(Fig. 2c, Additional file 6: Figure S6, fourth panel in each 
chromosome). Sixty-nine percent or 35 of these regions, 
match the deficient regions reported here. All of them 
contain H3K9me2/3 enriched domains in spermato-
cytes and nuclear lamina domains from ES cells. Caution 
must be exercised when studying peak deficiency in these 
regions due to their repetitive nature even though their 
special chromatin environments make them particularly 
interesting. Remarkably, Liu et al. [30] discovered a high 
degree of overlap with segmental duplications occupying 
47.7 % of cold regions.
The special value of the genetic data is that it describes 
recombination deficiency within these regions without 
being susceptible to any of the pitfalls of massive parallel 
sequencing alignments. Taken together with the molecu-
lar data, it appears that many of the genetically deficient 
regions derive from the failure of PRDM9 to activate 
Table 1 Recombination rates in the X-chromosome hotspot deficient region in female backcrosses








C57BL/6J × CAST/EiJ rs3653678–rs3670542 15.96 5 1092 0.029
NOD/LtJ × C3H/HeJ rs3653678–rs3656160 14.08 3 912 0.023
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recombination there, and that the deficient regions are 
common to multiple Prdm9 alleles due to their closed 
chromatin state.
DNA binding and hotspot usage
Figure 3a shows that among the many binding sites with 
similar PRDM9 affinities, only some are activated in vivo, 
indicating that activation involves an additional local 
factor. Figure 3b shows that this local factor depends on 
prior chromatin modifications and is overcome at sites 
with higher, intrinsic PRDM9 binding affinities (level 5 
on Fig.  3b). In vitro, under equilibrium conditions the 
affinity of PRDM9 binding to a DNA site, Kd, is the ratio 
of the off rate to the on rate of attachment. For macro-
molecular reactions, on rates are typically diffusion-lim-
ited, with the consequence that differences in Kd between 
hotspots describe differences in the off rate, which is 
inversely proportional to the average residence time of 
PRDM9 on its binding site.
In spermatocytes, the local chromatin state can create 
an energy barrier to PRDM9 binding in vivo. When this 
barrier is greater than the intrinsic energy of binding at a 
hotspot, binding is completely suppressed, and in regions 
such as closed chromatin where this barrier is typically 
higher, the result is a reduction in hotspot density. At 
hotspots where the barrier is only partial, it has the effect 
of reducing the net energy of binding, increasing the 
effective Kd in  vivo, and reducing the residence time of 
PRDM9. If the residence time determines the likelihood 
that PRDM9 will remain long enough to successfully tri-
methylate a hotspot, we would expect H3K4me3 levels at 
hotspots in closed chromatin to be typically less than at 
hotspots in open chromatin, and this is indeed the case 
(Fig. 4a).
Similar reasoning explains the observations that the 
PRDM9 ChIP sites we find in  vivo are typically those 
with the highest affinities in  vitro (Fig.  4b). Since we 
find only the top 10 % of all in vivo hotspots by PRDM9 
ChIP (1578 out of the 15,244 detected by H3K4me3 and/
or DMC1 hotspots), it is reasonable to assume that the 
more strongly PRDM9 molecules binds to DNA, the 
longer it will remain bound, increasing the chance of 
detecting interaction by ChIP. The difference between 
closed and open chromatin hotspots in the distribution 
of their in vitro PRDM9 affinities can be explained along 
the same lines—the energy barrier to binding is higher in 
heterochromatic regions, with the consequence that we 
detect hotspots with higher average DNA binding affinity 
there (Fig. 4c).
Overall, we conclude that whether PRDM9 binding 
sites are used in  vivo, and what their relative activities 
will be when they are used, depends on a local balance 
between the affinity of PRDM9 for its binding site and 
an energy barrier created by local chromatin modifica-
tions, and that these effects can have a major influence on 
genetic recombination patterns within species.
Discussion
Affinity‑seq provides a means for genome‑wide 
determination of long zinc finger protein binding sites
The human genome contains over 800 genes encoding 
proteins with zinc finger domains [31], more than half 
of which contain eight or more fingers organized in a 
Fig. 3 Affinity-seq binding site activities measured in vitro influ-
ence hotspot detection in vivo. a PRDM9 affinity to DNA and 
chromatin features determine hotspot activation qualitatively and 
quantitatively. Density distribution of Affinity-seq binding sites in 
hotspots detected in vivo (blue) or not detected (in vitro only, red) in 
spermatocytes compared to all sites (green). Active hotspots contain 
Affinity-seq binding sites with higher average activity compared to 
the sites detected in vitro only. b Closed chromatin state defined 
by H3K9me2/3 marks impacts lower affinity hotspots more strongly 
than higher affinity hotspots. We ranked hotspots by their affin-
ity for PRDM9 determined by Affinity-seq and divided them into 
five equal quintiles. For each group, we then calculated the ratio 
of hotspot number to total number of Affinity-seq sites in regions 
of closed chromatin (H3K9me2 or 3 positive) to regions of open 
chromatin (lacking H3K9me2 or me3). A ratio of 1 indicates no effect 
of heterochromatin. These data indicate that the strength of binding 
can increasingly overcome the effects of heterochromatin
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tandem fashion. Many of these genes function as tran-
scription factors, insulator binding proteins, or chroma-
tin modifiers. Previous methods of genome-wide analysis 
for examining DNA–protein interactions [32–34] have 
employed multiple rounds of selection and/or rand-
omized oligonucleotide DNA targets, approaches that 
either fail to determine relative binding affinities directly 
or to determine the actual repertoire of genomic bind-
ing sites. In contrast, Affinity-seq directly determines 
the relative affinity of tens of thousands of binding sites 
genome-wide with high binding specificity but with-
out the complications of successive rounds of selection. 
It also provides the opportunity for mutational analy-
sis of binding site specificities using alternate sources of 
genomic DNA. Using this assay, we showed that PRDM9 
binding specificity depends entirely on the terminal, 
tandem array of zinc fingers; the presence or absence of 
the first, widely separated, zinc finger may affect solu-
bility and/or stability but not the binding specificity. 
Although it is possible that adjacent or more remote pro-
tein domains might still affect binding specificity in other 
proteins, our results suggest that isolated ZnF domains 
can correctly represent the binding specificity of the 
entire protein in vivo.
In evidence of Affinity-seq’s utility, the present data 
clearly indicate that the binding specificity of the PRDM9 
zinc finger domain depends on all of the fingers except 
the first and last, not just those determining the extracted 
binding motif. Moreover, fingers with the same structure 
have different binding specificities depending on their 
location in the array (Fig. 1c). We expect that the Affin-
ity-seq strategy will prove applicable to other zinc-fin-
ger proteins and likely to other classes of DNA-binding 
proteins as well, providing a significant technology for 
exploring the molecular bases of DNA binding specificity 
beyond simply finding motifs.
Among Affinity-seq binding sites, about a half of them 
corresponds in location to biologically active recombina-
tion hotspots. They are precisely located at the central 
nucleosome deficient region characteristic of hotspots 
(Fig. 1b) and have the same computationally derived con-
sensus binding site (Fig. 1c) as that derived from hotspots 
defined by sites of H3K4 methylation [11] or DMC1 bind-
ing [9]. Multiple lines of evidence suggest that the other 
half of Affinity-seq binding sites, those not detected as 
biological hotspots in  vivo, are also true PRDM9 bind-
ing sites whose in vivo ability to activate recombination 
is suppressed by other biological factors. The two sets of 
sites, those detected in vivo and those not, have the same 
consensus PRDM9 binding motif derived by MEME 
and virtually the same frequency distribution of bases at 
each position in the binding site (Additional file  5: Fig-
ure S5). No previously undetected motifs were found in 
Fig. 4 Affinity-seq and H3K4me3 peak strength in closed vs. open chro-
matin. a Density plots of H3K4me3 signals in closed versus open chroma-
tin as determined by the absence or presence of H3K9me2/3 enrichment 
reveal that H3K4me3 signals are stronger at hotspots in open chromatin 
(blue) than in closed chromatin (red). In this analysis, DMC1 hotspots over-
lapping promoters were excluded. In all three panels, in order to eliminate 
effects of filtering multi-mapped reads only peaks which span regions 
of 100 % uniqueness in mappability were selected. Mann–Whitney test 
gives a p value <2.2 × 10−16 that distributions are the same. b PRDM9 
ChIP peaks are found at the sites with strongest affinity to DNA in vitro. 
Density plots are shown for Affinity-seq read counts normalized to parts 
per million at peaks for those sites detected by PRDM9 ChIP assay (red) 
and all sites (blue). Mann–Whitney test gives a p value <2.2 × 10−16 that 
distributions are the same. c Stronger affinities to DNA are detected at 
PRDM9 ChIP-seq peaks found in closed compared to open chromatin. 
Density plots are shown for Affinity-seq read counts normalized to parts 
per million at peaks in H3K9me2/3 enriched regions (red) and peaks at 
regions not enriched for H3K9me2/3 (blue). Mann–Whitney test gives a p 
value <2.2 × 10−16 that distributions are the same
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either group. What differences there are between the two 
groups, are best explained by the bias created by prior 
chromatin modifications towards stronger affinities for 
the sites used in vivo.
Given these results, it is reasonable to conclude that 
Affinity-seq correctly identifies intrinsic PRDM9 binding 
sites in genomic DNAs and that the observed constraints 
on binding site usage in  vivo correctly identify relevant 
biological factors.
Chromatin structure and hotspot usage
Early indications that differences in chromatin struc-
ture might play a role in hotspot usage in non-PRDM9 
organisms came with findings that hotspots in the bud-
ding yeast S. cerevisiae occur at nuclease-hypersensitive 
sites [35, 36]; that yeast recombination hotspots are 
marked by H3K4me3, and loss of the H3K4 methyltrans-
ferase SET1 results in the disappearance of normal hot-
spots with the emergence of new ones [37]; and that loss 
of the histone deacetylase SIR2 alters the distribution 
of yeast hotspots [38]. In contrast, in the fission yeast S. 
pombe, the role of H3K4me3 is replaced by acetylated 
H3K9 [39], a histone modification that is similarly con-
sidered as opening chromatin. The first indication that 
prior chromatin modifications might influence mamma-
lian hotspot activation came with the finding by Smagu-
lova et al. [10] that mammalian hotspots are more likely 
to occur in genic rather than intergenic regions. Among 
mammalian chromatin modifications that are likely to 
be involved, we now show that H3K9me2/3 marks are 
associated with a barrier to PRDM9 binding. Conversely, 
histone modifications that accompany transcription are 
associated with a lower threshold for PRDM9 binding 
to meiotic DNA as we find higher hotspot usage in gene 
bodies of expressed genes (Fig. 2b). These modifications 
include faster turnover of histone acetylation marks and 
H3K36me3 [40–42] and the acquisition of ubiquitinated 
H2BK120 [43, 44]. H3K36me3, like H3K4me3, is a mark 
of chromatin activation, and H2BK120ubi prevents com-
paction of chromatin into higher order structures [45]. 
Heterochromatin-specific and gene expression-specific 
marks probably affect hotspot usage independently. 
Silenced genes acquire tissue-specific H3K9me3 marks 
(Additional file 7: Figure S7) making it harder for PRDM9 
to bind there. During transcription, the gene expression 
associated H3K36me3 mark replaces H3K36ac, stabilizes 
the nucleosomes at the gene bodies and prevents cryptic 
transcription [46, 47], possibly facilitating PRDM9 bind-
ing and DSB initiation as well. Interestingly, PRDM9 has 
recently been shown to trimethylate H3K36 in addition 
to H3K4 in  vitro [48], suggesting a possible role of this 
histone modification in recombination initiation.
Conclusions
Our work provides a novel approach for studying DNA–
protein interactions. Its application to PRDM9 leads to 
the finding that recombination hotspot usage is modu-
lated by the local chromatin state, which can reasonably 
be explained by the latter’s influence on the energetics of 
PRDM9 binding. These constraints lead to the presence 
of long genomic regions depleted of recombination. The 
approach described here provides a conceptual frame-




The C-terminal fragment of PRDM9Dom2 lacking the sep-
arate zinc finger (412–843 AA) was cloned into pH6HTN 
His6HaloTag® T7 Vector (Promega) using Pvu I—Not I 
restriction sites.
Expression and cell lysate preparation
The protein was expressed in Rosetta cells (Merck Mil-
lipore) at 37  °C for 4  h. The cells were centrifuged at 
3000g for 5 min, and the cell pellet from 100 ml culture 
was resuspended in 8 ml of 50  mM sodium phosphate, 
100  mM sodium chloride, pH 8.0, containing 16  mg 
lysozyme, and incubated on ice 30’. The lysate was frozen 
overnight at −80  °C. The next day, the lysate was soni-
cated using three 10-s bursts at medium intensity, then 
frozen and sonicated again under the same conditions.
The first purification step—ion exchange on SP-Sepha-
rose (cat.#17-1087-01, GE Healthcare Life Sciences, 
Piscataway, NJ, USA), was performed using an NaCl step-
wise gradient. The active protein was eluted at 300 mM 
salt concentration. The active fractions were pooled and 
subjected to a second round of purification on affinity 
chromatography using Ni2+ resin (cat.#88221, Thermo 
Scientific Pierce, Rockford, IL, USA) according to manu-
facturer’s specifications. Active fractions were eluted at 
250 mM imidazole.
The quantity of the purified 6His-HALO-PRDM9 was 
determined by band comparison to BSA standards on 
silver-stained gels.
Affinity‑seq
Genomic DNA was sonicated to an average of ~200  bp 
length using a Covaris M220 high-speed digital sonicat-
ing water bath (Covaris, Inc., Woburn, MA, USA). In a 
separate tube, HaloTag® PEG-Biotin Ligand (cat. #G8591, 
Promega Corporation, Madison, WI, USA) was added to 
100 µl purified 6His-HALO-PRDM9 (~2.5 pM) to 1 µM 
final concentration and the mixture was incubated 2–4 h 
at room temperature.
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Binding reaction was performed by combining 20 μl of 
10 × binding buffer (100 mM Tris, 500 mM KCl, 10 mM 
DTT pH 7.5), 10 μl of 1 % NP40, 20 µg sonicated DNA 
(3–5 × 1012 binding sites) and 7 µl of PEG-Biotin labeled 
protein sample (~0.16  pM protein or ~1011 molecules). 
The reaction mixture was incubated for 4 h at room tem-
perature with rotation.
Fifty microliters MyOne T1 streptavidin beads (cat. 
#65601, Life Technologies Thermo Fisher Scientific) were 
washed three times with 0.5  ml TBST (TBS contain-
ing 0.05 % Tween 20), capturing particles with a magnet 
between washes. After the last wash, the bound samples 
were added and incubated for 30 min at room tempera-
ture on a rotating wheel. The beads were washed three 
times with 1.0 ml TBST containing 0.5 mg/ml BSA.
Protein-DNA complexes were eluted from the beads by 
adding 24 µl 1 % SDS and 16 μl 20 mM Tris pH 7.5, and 
incubating at 68 °C overnight with shaking. DNA was puri-
fied through Qiagen mini-elute (cat #28206, Qiagen) col-
umn. The eluted DNA was used to prepare an Illumina® 
sequencing library using the ChIP-seq protocol. About 80 
million reads were obtained from each individual library.
DNA sequence analysis
Two replicate Affinity-seq samples were sequenced at 100-
bp reads using the Illumina HiSeq 2500 and subsequently 
trimmed for quality using trimmomatic. Alignments to the 
mm9 mouse genome were obtained utilizing BWA v1.2.3 
[49] with default parameters and reads which failed to align 
to unique positions in the genome were discarded. This 
achieved alignments of 68.89 million reads in one sample 
and 105.53 million reads in another. Peaks were called indi-
vidually with MACS2 at a p value threshold of 0.01 utiliz-
ing a control dataset obtained by sequencing the input 
DNA and subsequently compared. Both datasets were 
subjected individually to motif analysis with MEME Suite 
(v 4.10.1) for motif discovery and sequence searching [50] 
using default parameters. For each site, a p value threshold 
of 0.001 was used. The 150  bp central peak regions were 
processed by MEME on a chromosome by chromosome 
basis. In all runs only a single motif was ever found, which 
matched previously published B6 motifs with only subtle 
differences between nucleotide frequencies. The surround-
ing 150 bp regions on both sides of the peak regions were 
tested separately; no significant motif was found.
SNPs between C57BL/6J and CAST/EiJ were obtained 




ChIP-seq data for anti-H3K4me3 obtained from C57BL/6J 
(B6) and the co-isogenic strain, B6-Prdm9CAST-KI/Kpgn (B6.
P9Cst), which has the CAST/EiJ Prdm9 allele placed into 
the C57Bl/6J background, were reported by Baker et  al. 
[11]. Data are available at NCBI Gene Expression Omnibus 
(GEO; http://www.ncbi/nlm/nih.gov/geo/) under accession 
number GSE52628.
H3K9me2 and H3K9me3 ChIP
ChIP for either of these two histone modifications was 
carried out using an identical protocol to that used for 
H3K4me3 ChIP, except using antibody to H3K9me2 
(Abcam ab1220) or H3K9me3 (Active Motif 39766). The 
sequence files were subjected to the same pipeline uti-
lized for the Affinity-seq samples.
For the H3K9me2/3 samples peaks were called using 
a Rseg, a Hidden Markov approach to determining long 
domains of enrichment over a control samples. Enriched 
regions were visualized by performing chromosome 
walks of both sample and control and calculating a log 
base twofold ratio for reads in every 2 kb interval.
PRDM9 ChIP
This ChIP was performed using antibody against the 
N-terminal fragment of mouse PRDM9 (101–170 aa) 
elicited in guinea pig. The ChIP protocol and analysis 
were carried out as described in [19]. PRDM9 ChIP sam-
ples were subjected to the same pipeline utilized for the 
Affinity-seq samples. Peaks for PRDM9 ChIP were called 
using MACS1.4 at a p value threshold of 0.00001 and 
removing duplicate reads.
RNA‑seq
RNA was extracted from four replicates of B6 germ cells 
enriched from testes at 12  dpp by enzymatic digestion. 
For each sample, mRNA was extracted from total RNA, 
fragmented, and purified. Barcoded sequencing librar-
ies were prepared according to manufacturer’s protocols 
(Illumina®; San Diego, CA, USA). Briefly, double-stranded 
cDNA was made using random primers, overhangs were 
converted into phosphorylated blunt ends, and sample-
specific adaptors (including 8-bp “barcodes”) were ligated 
to the DNA fragments. PCR was performed to enrich for 
the adapter-modified DNA fragments, and the librar-
ies were validated using an Agilent Technologies 2100 
Bioanalyzer. Sequencing was performed by The Jackson 
Laboratory’s Gene Expression Service using the Illumina® 
HiSeq platform. Each sample was sequenced to a depth of 
approximately 25 million 100-bp, paired-end reads.
The RNA-seq data underwent pre-processing and qual-
ity control measures, including initial data calibration and 
filtering using Illumina® Inc.’s Real Time Analysis (RTA) 
software and chastity filter. Gene expression levels were 
quantified by aligning reads to the mouse reference genome 
(NCBI build 37) using the BowTie 0.12.9 alignment software 
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[51], using the NCBIm37 transcriptome as a reference. We 
filtered out reads with two or more mismatches against the 
reference transcriptome, accepting those with the minimum 
number of mismatches for each of 100 bp read (‘–all’, ‘–best’, 
and ‘–strata’ options were used). Normalized expression 
level per gene was calculated in fragments per kilobase of 
transcript per million mapped reads (FPKM) using RSEM 
version 1.2.8 using the following parameters: –fragment–
length–mean 280 and –fragment–length–sd 50 [52].
Statistical analysis of DNA‑seq and RNA‑seq data
Custom software for processing bedgraph, BAM/SAM 
files and bedfiles, and RNA-Seq data were developed in 
the Java programming language containing open-source 
frameworks BioJava v3.04 and SAM-JDK version 1.92. 
Bioinformatics tools utilized in analyses included Illu-
mina® Casava v1.8, BWA v1.2.3 [49], samtools v0.1.19 
based on SAM Spec v1.4 [53], and BEDTools v2.17.0 [54].
Rscan
Regions deficient in H3K4me3/DMC1 in  vivo hotspots 
along chromosomes were determined using an r-scan 
statistic based on the Karlin and Macken method in 
which the significance of spans is calculated empirically 
to take into account ends of chromosomes [28]. Rscans 
are distance measurements between subjects that are 
near one another but not always adjacent. Additional 
degrees of dispersion can be detected by looking at dis-
tances between near neighbors where gaps between 
adjacent members may not be significantly large yet col-
lectively a group of consecutive subjects can be signifi-
cantly distanced from one another.
Given a genome of nc hotspots on each chromosome, 
c, there are nc − 1 interhotspot intervals or distances that 
are the difference in rank between the ith and (i + 1)th 
hotspots, denoted as Ui. For any chromosome with nc 
hotspots, the base-pair distances in r-scan lengths (r = 1, 
2, 3,…) between hotspots is calculated as follows:
The set of r-scan lengths from all chromosomes, Ri(r), 
is ranked in descending order. Let mk(r) be the kth larg-
est r-scan length from the ordered set, Ri(r). For each 
observed r-scan length in the test set, the probability of 
its being due to chance was determined from the cumula-
tive frequency distribution.
For any given set of genomic locations we evaluate 
algorithmically distance measurements between loca-
tions that range from immediately consecutive distances 
between locations to locations that are up to 24 consecu-






Uj, i = 1, 2, . . . , nc − r
of randomly selected hotspots equal in number to the test 
set, the cumulative frequency distribution of m(r)k  for all k 
and 1 ≤ r ≤ 24 were computed. Only the top 10 ranked dis-
tances for each consecutive distance are evaluated. Proba-
bilities assigned to Ri(r) observed in the test set were adjusted 
using the Benjamini–Hochberg false discovery rate method 
[55]. Test-set hotspots were denoted as dispersed if they 
were bounded by an r-scan length that was the 10th or 
lower ranked length (k ≤ 10) and had an adjusted probabil-
ity less than 0.05. Significant r-scan intervals were merged 
together to form putative hotspot-deficient regions. An 
ascending ordered list is utilized for clustering analysis and 
a descending ordered list for dispersion analysis.
Effectively, this approach is looking for unusually long 
distances not only between adjacent hotspots, but also 
for accumulation of dispersion of distances over up to 24 
interhotspot intervals, and allows merging adjacent dis-
persed intervals. Given the average interhotspot distance 
of 87  kb between Affinity-seq binding sites and 182  kb 
between the in  vivo hotspots, the approach can detect 
hotspot-depleted regions on a Megabase scale size.
Data access
Data have been deposited at NCBI’s Gene Expression 
Omnibus and are accessible through GEO Series acces-
sion number GSE61613 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE61613).
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